# Autobahn Therapeutics, Inc. — Form D

Autobahn Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-01. The offering totals $120.0M, of which $100.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-01
- Form: D
- Accession: 0001815098-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $120.0M
- Amount sold: $100.8M
- Remaining: $19.2M
- Investors: 22
- Date of first sale: 2024-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520406

## Issuer

- Name: Autobahn Therapeutics, Inc.
- CIK: 0001815098
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9880 CAMPUS POINT DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-257-3418

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Timothy Anderson | Director | San Diego, CA |
| Kristina Burow | Director | San Diego, CA |
| Thomas Cahill | Director | Boston, MA |
| Benjamin Cravatt | Director | San Diego, CA |
| Philip J DeSouza | Director | San Diego, CA |
| Kevin Finney | Director | San Diego, CA |
| Scott Giacobello | Director | MORRISTOWN, NJ |
| Uwe J Schoenbeck | Director | San Diego, CA |
| Bonnie J van Wilgenburg | Director | San Diego, CA |
| John Borkholder | Executive Officer | San Diego, CA |
| Kevin Finney | Executive Officer | San Diego, CA |

## More

- [CIK 1815098 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1815098&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001815098-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.